Ozempic (semaglutide) is emerging as a promising player in the future of Dubai's fight against diabetes. This injectable medication, belonging to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), goes beyond just managing blood sugar.